ADCT - Adc Therapeutics SA
4.88
0.080 1.639%
Share volume: 1,270,671
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$4.80
0.08
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-06-2024 | 11-07-2024 | 03-27-2025 | 05-14-2025 | 11-10-2025 | |
| Assets | |||||||
| Total Assets | 307.966 M | 371.779 M | 349.079 M | 321.980 M | 272.539 M | 289.758 M | |
| Current Assets | 290.206 M | 355.359 M | 333.005 M | 307.390 M | 257.989 M | 287.149 M | |
| Inventories | 15.997 M | 15.191 M | 16.072 M | 18.387 M | 17.447 M | 18.042 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 9.450 M | 7.180 M | 5.523 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 234.285 M | 300.119 M | 274.272 M | 250.867 M | 194.701 M | 234.738 M | |
| Total Non-current Assets | 930.000 K | 260.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.785 M | 5.483 M | 5.721 M | 5.075 M | 5.156 M | 0.000 | |
| Other Assets | 11.975 M | 10.937 M | 10.353 M | 9.515 M | 9.394 M | 2.609 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 307.966 M | 371.779 M | 349.079 M | 321.980 M | 272.539 M | 289.758 M | |
| Total liabilities | 502.415 M | 503.449 M | 521.025 M | 524.622 M | 510.762 M | 527.941 M | |
| Total current liabilities | 62.985 M | 57.632 M | 67.679 M | 80.469 M | 57.794 M | 62.044 M | |
| Accounts Payable | 14.315 M | 10.708 M | 14.372 M | 18.029 M | 15.592 M | 8.119 M | |
| Other liabilities | 326.196 M | 332.144 M | 339.157 M | 330.521 M | 339.145 M | 350.691 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 113.234 M | 113.673 M | 114.189 M | 113.632 M | 113.823 M | 115.206 M | |
| Other liabilities | 326.196 M | 332.144 M | 339.157 M | 330.521 M | 339.145 M | 350.691 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -194.449 M | -131.670 M | -171.946 M | -202.642 M | -238.223 M | -238.183 M | |
| Common stock | 1.188 B | 1.288 B | 1.291 B | 1.292 B | 1.295 B | 1.392 B | |
| Retained earnings | -1.382 B | -1.419 B | -1.463 B | -1.493 B | -1.532 B | -1.630 B |